Jefferies Identifies 5 Stocks with 'Buy' Recommendations and Price Targets

Jefferies has reaffirmed its 'Buy' rating on ITC with a price target of Rs 535, anticipating a 27% upside. The brokerage notes sustained cigarette volume growth and premiumisation, with reasonable valuations. For Dabur India, Jefferies maintained its 'Buy' rating and a target of Rs 610, expecting 22% upside, citing strong performance in oral care and personal care categories and a positive outlook for rural recovery.

In the chemicals sector, Navin Fluorine International received a 'Buy' reiteration and an increased target price of Rs 6,635, suggesting a 32% potential gain. Jefferies highlighted robust growth across all its verticals and projected the strongest earnings growth in its chemical coverage.

NTPC also received a 'Buy' rating with a target of Rs 440, representing a 26% upside. Despite a slight reduction in capacity addition guidance, Jefferies remains positive due to NTPC's growing renewable pipeline and strong long-term growth drivers.

Jefferies initiated coverage on Swiggy with a 'Buy' rating and a target of Rs 500, implying a 19% upside. The firm sees Swiggy as a high-growth franchise with a clear path to profitability by FY28, although it cautioned that an upcoming capital raise might limit short-term gains.

Impact: This news is highly relevant for Indian stock market investors, as it provides actionable insights from a reputable brokerage firm. The 'Buy' recommendations on specific stocks can lead to increased investor interest and potentially drive their stock prices higher. Investors can use these recommendations to inform their investment decisions, considering the provided price targets and rationales. The news can influence portfolio allocation and trading strategies for individuals and institutional investors alike. Rating: 8/10

Heading: Defined Terms EBIT (Earnings Before Interest and Taxes): A measure of a firm's profit that includes interest expenses and tax expenses. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): A measure of a firm's overall financial performance, used as an alternative to net income to provide a measure of a company's operating performance. CAGR (Compound Annual Growth Rate): The mean annual growth rate of an investment over a specified period of time longer than one year. CDMO (Contract Development and Manufacturing Organization): A company that provides drug development and manufacturing services to pharmaceutical companies. GOV (Gross Order Value): The total value of all orders processed through a platform before deductions. Sum-of-the-parts valuation: A method of valuing a company by adding up the estimated values of its individual business segments. Premiumisation: The strategy of marketing products or services as high-quality or exclusive, often at a higher price point. Channel destocking: The process where retailers or distributors reduce their inventory levels. EPS (Earnings Per Share): The portion of a company's profit allocated to each outstanding share of common stock. Capex (Capital Expenditure): Funds used by a company to acquire, upgrade, and maintain physical assets such as property, industrial buildings, or equipment. Breakeven: The point at which total cost and total revenue are equal.